The Indo German clinical research major Ecron Acunova, a cent per cent subsidiary of Manipal Acunova, with its established presence in India and Europe is scouting for more market share in clinical research in these countries and other parts of the globe.

Ecron Acunova is a leading clinical research organisation (CRO) providing end-to-end services for phase I to phase IV clinical research, including clinical trial management, clinical data management, PK/PD services and central lab for the global pharmaceutical, biotechnology, medical device and healthcare industries.

Ecron Acunova combines 20 years' clinical research expertise of Ecron and Manipal Acunova's association with India's largest medical university. Manipal Acunova is a collaborative venture between the Manipal Education and Medical Group International India and AcuNova Life Sciences.

"Ecron Acunova represents a synergism of more than two decades of European full service CRO Ecron's experience and the expertise of Indian pioneer CRO AcuNova. In our offices across Europe, Asia and the USA we translate this combination of cultures and capabilities into innovative solutions according to our clients' needs, accelerating the 'pharma time-to-market' with no compromise on quality. Besides, as regional experts, we consider and operate in each region as a priority market," said, Dr Antal K Hajos, managing director and CEO, Ecron Acunova Europe.

Ecron Acunova has research facilities in India as well as established presence across Europe and the USA. Its headquarters are located in Frankfurt, Bangalore and Princeton.

In Europe, Ecron Acunova manages its business from nine offices and has direct operations in Germany, UK, France, Italy, Ukraine, Poland and Czech Republic. Further locations are accessible through its dedicated and harmonised partners in other countries across Europe.

The company has received industry recognition as experts for their geographical competence and varied therapeutic expertise in phase II-IV clinical trials in both Western Europe and Eastern Europe.

"With direct presence across both Central and Eastern Europe (CEE) and India, Ecron Acunova leverages competitive advantages in clinical research by combining the wealth of experience and quality standards of the Western European market with the fast patient recruitment and low cost advantages of the CEE market as well as India," apprised Dr Antal K Hajos.